Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer

Gynecologic Oncology

Volumn 75, Issue 1, 1999, Pages 25-33

  Brown, Theodore J ^a   Shaw, Patricia A ^a   Karp, Xantha ^a   Huynh, My Hang ^a   Begley, Heather ^a   Ringuette, Maurice J ^a  

^a NONE

Author keywords

BM 40; Extracellular matrix; Osteonectin; Ovarian cancer; Ovarian stroma; Ovary; SPARC

Indexed keywords

CALCIUM BINDING PROTEIN; GLYCOPROTEIN; MESSENGER RNA; OSTEONECTIN;

ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CONTROLLED STUDY; EPITHELIUM; FEMALE; GRANULOSA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; OVARY CARCINOMA; OVARY FOLLICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THECA CELL; TUMOR GROWTH;

EID: 0032880280     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5552     Document Type: Article

References (34)

1. Sage H, Vernon R B, Decker J, Funk S, Iruela-Arispe M L. Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice. J Histochem Cytochem. 37:1989;819-829.
2. Lane T F, Sage E H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8:1994;163-172.
3. Hay E D. Collagens and Other Matrix Glycoproteins in Embryogenesis. Wood E F. Cell Biology of Extracellular Matrix. 1991;419-463 Plenum Press, New York.
4. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. Int J Cell Biol. 130:1995;503-506.
5. Young M F, Bolander M E, Day A A, Ramis C I, Robey P G, Yamada Y, Termine J D. Osteonectin mRNA:distribution in normal and transformed cells. Nucleic Acids Res. 14:1986;4483-4497.
6. Mok S C, Chan W Y, Wong K K, Muto M G, Berkowitz R S. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene. 12:1996;1895-1901.
7. Nelson P S, Plymate S R, Wang K, True L D, Ware J L, Gan L, Liu A Y, Hood L. Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma. Cancer Res. 58:1998;232-236.
8. Ledda F, Bravo A I, Adris S, Bover L, Mordoh J, Podhajcer O L. The expression of the secreted protein acidic rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J Invest Dermatol. 108:1997;210-214.
9. Porter L, Sage E H, Lane T F, Funk S E, Gown A M. Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem. 43:1995;791-800.
10. Porte H, Chaste E, Prevot S, Norlindger B, Empereur S, Basset P, Chambon P, Gespacah C. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromolysin-3 and BM-40/SPARC genes. Int J Cancer. 64:1995;70-75.
11. Schulz A, Jundt G, Berghauser K-H, Gehron-Robey P, Termine J D. Immunohistochemical study of osteonectin in various types of osteosarcoma. Am J Pathol. 132:1988;233-238.
12. Porte H, Triboulet L K, Carrat F, Prévot S, Nordlinger B, DiGioia Y, Wurtz A, Comoglio P, Gespach C, Chastre E. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. Clin Cancer Res. 4:1998;1375-1382.
13. Rempel S A, Ge S, Gutiérrez J A. SPARC: a potential diagnostic marker of invasive meningiomas. Clin Cancer Res. 5:1999;237-241.
14. Damjanovski S, Malaval L, Ringuette M J. Transient expression of SPARC in the dorsal axis of early Xenopus embryos: correlation with calcium-dependent adhesion and electrical coupling. Int J Dev Biol. 38:1994;439-446.
15. Damjanovski S, Karp X, Funk S, Sage E H, Ringuette M J. Ectopic expression of SPARC in Xenopus embryos interferes with tissue morphogenesis: identification of a bioactive sequence in the C-terminal EF hand domain. J Histochem Cytochem. 45:1996;643-655.
16. Nomura S, Wills A J, Edwards D R, Heath J K, Hogan B LM. Developmental expression of 2ar (Osteopontin) and SPARC (Osteonectin) RNA as revealed by in situ hybridization. J Cell Biol. 106:1988;441-450.
17. Reed M J, Puolakkainen P, Lane T F, Dickerson D, Bornstein P, Sage E H. Differential expression of SPARC and thrombospondin in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem. 41:1993;1467-1477.
18. Motamed K, Sage E H. Regulation of vascular morphogenesis by the matricellular protein SPARC. Kindey Int. 51:1997;1383-1387.
19. Sage E H. Terms of attachment: SPARC and tumorigenesis. Nature Med. 3:1997;144-146.
20. Young M F, Day A A, Dominquez P, McQuillan C I, Fisher L W, Termine J D. Structure and expression of osteonectin mRNA in human tissue. Connect Tissue Res. 24:1990;17-28.
21. Domenicucci C, Goldberg H A, Hofmann T, Isenman D, Wasi S, Sodek J. Characterization of porcine osteonectin extracted from foetal calvariae. Biochem J. 253:1988;139-151.
22. Bagavandoss P, Sage E H, Vernon R B. Secreted protein, acidic and rich in cysteine (SPARC) and thrombospondin in the developing follicle and corpus luteum of the rat. J Histochem Cytochem. 46:1998;1043-1049.
23. Holland P W, Harper S J, McVey J H, Hogan B L. In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization. J Cell Biol. 105:1987;473-482.
24. Simon A M, Goodenough D A, En L, Paul D L. Female infertility in mice lacking connexin 37. Nature. 385:1997;525-529.
25. Campo E, Merino M J, Tavassoli F A, Charonis A S, Stetler-Stevenson W G, Liotta L A. Evaluation of basement components and the 72 kDa type IV collagenase in serous tumors of the ovary. Am J Surg Pathol. 16:1992;500-507.
26. Gooden M D, Vernon R B, Bassuk J A, Sage E H. Cell cycle-dependent location of the matricellular protein SPARC: association with the nuclear matrix. J Cell Biochem. 74:1999;152-167.
27. Rempel S A, Golembieski W A, Ge S, Lemke N, Elisevich K, Mikkelsen T, Gutierrez J A. SPARC: a signal of astrocytic neoplasia transformation and reactive response in human primary and xenograft gliomas. J Neuropathol Exp Neurol. 57:1998;1112-1121.
28. Zhu G G, Risteli J, Puistola U, Kauppila A, Risteli L. Progressive ovarian carcinoma induces synthesis of type I and type III procollagens in the tumor tissue and peritoneal cavity. Cancer Res. 53:1993;5028-5032.
29. Fishman D A, Kearns A, Chilikuri K, Bafetti L M, O'Toole E, Ravosa M J, Stack M S. Epithelial ovarian carcinoma metastatic dissemination is stimulated by type I collagen. Soc Gynecol Invest. 5S:1998;76A-77A.
30. Moser T L, Pizzo S V, Bafetti L M, Fishman D A, Stack M S. Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin. Int J Cancer. 67:1996;695-701.
31. Maurer P, Hohenadl C, Hohenester E, Gohring W, Timpl R, Engel J. The C-terminal portion of BM-40 (SPARC/Osteonectin) is an autonomously folding and crystallizable domain that binds calcium and collagen IV. J Mol Biol. 253:1995;347-357.
32. Shankavaram U T, DeWitt D L, Funk S E, Sage E H, Wahl L M. Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol. 173:1997;327-334.
33. Raines E W, Lane T F, Iruela-Arispe M L, Ross R, Sage E H. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA. 89:1992;1281-1285.
34. Skobe M, Fuseng N E. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc Natl Acad Sci USA. 95:1998;1050-1055.